Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 4, Issue 2, Pages 93-96Publisher
IOS PRESS
DOI: 10.3233/JAD-2002-4203
Keywords
Pentosidine; AGE; Alzheimer's disease
Categories
Ask authors/readers for more resources
Pentosidine, an advanced glycation end product (AGE), was assayed by HPLC in serum proteins from patients with Alzheimer type dementia (AD), patients with diabetes mellitus (D), and healthy (C) age-matched old subjects (mean age from each group = 84 years). Serum pentosidine was significantly different between the three groups despite similar renal function (serum creatinine < 160 mu mol/L). In all groups of patients, pentosidine was independent of glycated hemoglobin (HbA1C) and the early glycation marker fructosamine and appeared to be an independent marker, mainly bound to serum albumin. Pentosidine could be an important factor useful for the diagnosis of Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available